Changing Biogen

Biogen Idec's new CEO, George Scangos, has a vision to bring new energy and "vitality" to the company and change its culture, says Reuters' Toni Clarke. The former Exelixis CEO wants Biogen to be more flexible — since taking over the company, he has cut costs, focused on priorities in the pipeline, and reorganized the management structure, Clarke says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.